您的位置: 首页 > 农业专利 > 详情页

ST2 SOLUBLE EN TANT QUE MARQUEUR DE MALADIE CARDIOVASCULAIRE ET CIBLE THERAPEUTIQUE
专利权人:
THE BRIGHAM AND WOMEN'S HOSPITAL; INC.;THE BRIGHAM AND WOMENS HOSPITAL
发明人:
LEE, RICHARD T.
申请号:
CA2484897
公开号:
CA2484897C
申请日:
2003.05.09
申请国别(地区):
CA
年份:
2015
代理人:
摘要:
The invention pertains to methods for predicting outcome of a cardiovascularcondition in a subject, diagnosing a cardiovascular condition in a subject,evaluating thelikelihood that a subject will benefit from treatment with an agent forreducing the risk of acardiovascular condition, selecting a treatment for reducing the risk of acardiovascularcondition for a subject, selecting a subject for treatment for reducing therisk of acardiovascular condition, and selecting a subject for participation in acardiovascularcondition clinical trial, that include determining a level of soluble ST2 in asample from thesubject. In particular, the invention relates to methods for predicting theoutcome of acardiovascular condition in a subject, which comprise determining a level ofsoluble ST2 in abiological sample wherein an elevated level of soluble ST2 relative to apredetermined valueis indicative of a negative outcome of a cardiovascular condition, and adecreased level ofsoluble ST2 relative to a predetermined value is indicative of a positiveoutcome of acardiovascular condition.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充